Trident Lifeline Ltd (TIDT)

Currency in INR
264.10
+4.10(+1.58%)
Closed·
TIDT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
260.90271.00
52 wk Range
229.95328.00
Key Statistics
Bid/Ask
251.00 / 264.10
Prev. Close
260
Open
268
Day's Range
260.9-271
52 wk Range
229.95-328
Volume
39K
Average Volume (3m)
35.73K
1-Year Change
-0.4148%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TIDT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
07/05/2026
EPS / Forecast
5.82 / --
Revenue / Forecast
576.82M / --
EPS Revisions
Last 90 days

TIDT Income Statement

Compare TIDT to Peers and Sector

Metrics to compare
TIDT
Peers
Sector
Relationship
P/E Ratio
16.3x34.2x−0.4x
PEG Ratio
0.270.330.00
Price/Book
3.1x3.9x2.6x
Price / LTM Sales
2.4x3.2x3.0x
Upside (Analyst Target)
-3.5%51.9%
Fair Value Upside
Unlock−1.6%9.4%Unlock

Trident Lifeline Limited, together with its subsidiaries, manufactures and markets finished doses in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. The company offers various medicinal products, including pharmaceuticals, nutraceuticals, herbals, and injectables in the form of tablets, capsules, dry powders for oral suspension, oral liquids, ointments, liquid ointments, effervescent tablets, sachets, pastes, gels, solutions, suspensions, ice gels, syrups, and creams, as well as toothpaste and mouthwash. Its products target a range of therapeutic solutions, such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, dental cure, proton pump inhibitor, antiprotozoal, antihistamine, antihypertensive drugs, antiparasitic, antilipidemic drugs, multivitamins, multiminerals, and non-steroidal anti-inflammatory drugs. The company is also involved in the manufacturing of formulations under proprietary brands; contract manufacturing arrangements; manufacture, trade, and distribution of skin and hair cosmetic products; and medical devices. It exports its products. The company has a strategic alliance with National Institutes of Pharmaceutical Education and Research- Ahmedabad (NIPER-A) for the technology transfer of Vorinostat, a medication for Cutaneous T-Cell Lymphoma (CTCL). Trident Lifeline Limited was incorporated in 2014 and is based in Surat, India.

Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
2.42M20.30%629.95M
Public Companies & Retail Investors
9.51M79.70%2.47B
Total
11.93M100.00%3.1B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Turning Leaf Asset Management Pte. Ltd.5.43%648,000168,480
Nav Capital VCC- Nav Capital Emerging Star Fund5.43%648,000168,480

People Also Watch

120.00
AERF
+2.74%
140.05
MITU
+0.61%
57.25
RNIT
-2.97%
218.60
TAMB
0.00%
643.30
ONIX
-2.00%

FAQ

What Is the Trident Lifeline (TIDT) Stock Price Today?

The Trident Lifeline stock price today is 264.10 INR.

What Stock Exchange Does Trident Lifeline Trade On?

Trident Lifeline is listed and trades on the Bombay Stock Exchange.

What Is the Stock Symbol for Trident Lifeline?

The stock symbol for Trident Lifeline is "TIDT."

What Is the Trident Lifeline Market Cap?

As of today, Trident Lifeline market cap is 3.10B INR.

What Is Trident Lifeline's Earnings Per Share (TTM)?

The Trident Lifeline EPS (TTM) is 16.32.

From a Technical Analysis Perspective, Is TIDT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Trident Lifeline Stock Split?

Trident Lifeline has split 0 times.

What is the current trading status of Trident Lifeline (TIDT)?

As of 09/07/2026, Trident Lifeline (TIDT) is trading at a price of 264.10 INR, with a previous close of 260.00 INR. The stock has fluctuated within a day range of 260.90 INR to 271.00 INR, while its 52-week range spans from 229.95 INR to 328.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.